Catalysts for Bayer AG
86 tracked
Apr 30, 2026
phase 1 2 completion
Bayer AG — avelumab (Phase I/II Trial Completion)
avelumab
→
Apr 29, 2026
phase 1 initiation
Bayer AG — asundexian (Phase I Trial Initiation)
asundexian
→
Mar 31, 2026
device adverse event
ESSURE — Injury event
Bayer AG
→
Mar 31, 2026
device adverse event
ESSURE — Injury event
Bayer AG
→
Mar 31, 2026
device adverse event
ESSURE — Injury event
Bayer AG
→
Mar 31, 2026
device adverse event
ESSURE — Injury event
Bayer AG
→
Mar 10, 2026
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Feb 3, 2026
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Apr 24, 2025
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Feb 25, 2025
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Sep 11, 2024
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Apr 4, 2023
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Mar 10, 2022
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Apr 1, 2021
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Dec 31, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Dec 31, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Dec 31, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Dec 31, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Dec 10, 2020
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Oct 28, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Sep 24, 2020
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Jul 21, 2020
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
May 8, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Apr 23, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Mar 2, 2020
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Feb 13, 2020
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Aug 7, 2019
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Jul 31, 2019
approval
STIVARGA (REGORAFENIB) — FDA approval
Bayer AG
→
Jul 23, 2019
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→
Jul 2, 2019
approval
ALEVE (NAPROXEN SODIUM) — FDA approval
NAPROXEN SODIUM
→